SEI Trust Company’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$31.4M Buy
583,463
+197,509
+51% +$10.5M 0.3% 75
2014
Q2
$20.2M Buy
385,954
+69,194
+22% +$3.54M 0.2% 137
2014
Q1
$16.7M Sell
316,760
-10,150
-3% -$469K 0.17% 155
2013
Q4
$13.1M Buy
326,910
+52,310
+19% +$2.06M 0.12% 195
2013
Q3
$10.4M Buy
274,600
+32,000
+13% +$1.25M 0.11% 214
2013
Q2
$9.51M Buy
+242,600
New +$9.45M 0.12% 215

Other funds holding TEVA

SEI Trust Company's TEVA Position: Q3 2014 in Review

SEI Trust Company increased its Teva Pharmaceuticals (TEVA) stake by 51% in Q3 2014, buying an estimated $10.5M and bringing the position to 583,463 shares worth $31.4M. The position accounts for 0.3% of the portfolio, ranked #75.

SEI Trust Company first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • SEI Trust Company held 583,463 shares of Teva Pharmaceuticals worth $31.4M as of Q3 2014.
  • SEI Trust Company bought 197,509 Teva Pharmaceuticals shares in Q3 2014, an estimated $10.5M.
  • Teva Pharmaceuticals made up 0.3% of SEI Trust Company's portfolio in Q3 2014, its #75 holding.
  • SEI Trust Company first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.